Logo image of BCR

BARD C R INC (BCR) Stock Price, Quote, News and Overview

NYSE:BCR - New York Stock Exchange, Inc. - US0673831097

331.24  -1.95 (-0.59%)

After market: 331.97 +0.73 (+0.22%)

BCR Quote, Performance and Key Statistics

BARD C R INC

NYSE:BCR (12/28/2017, 8:18:13 PM)

After market: 331.97 +0.73 (+0.22%)

331.24

-1.95 (-0.59%)

Sector
GICS SectorN/A
GICS IndustryN/A
GICS IndustryGroupN/A
GICS SubIndustryN/A
Statistics
52 Week High337.73
52 Week Low224.31
Market Cap24.14B
Shares72.89M
Float72.89M
Yearly Dividend1.04
Dividend Yield0.24%
PE43.42
Fwd PE25.52
Earnings (Next)N/A N/A
IPON/A N/A


BCR short term performance overview.The bars show the price performance of BCR in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 0 2 4

BCR long term performance overview.The bars show the price performance of BCR in the last 1, 2 and 3 years. 1 year 2 years 3 years 10 20 30 40

The current stock price of BCR is 331.24 null. In the past month the price decreased by -1.65%. In the past year, price increased by 47.44%.

BARD C R INC / BCR Daily stock chart

About BCR

Company Profile

C. R. Bard, Inc., together with its subsidiaries, designs, manufactures, packages, distributes, and sells medical, surgical, diagnostic, and patient care devices worldwide. The company offers vascular products, such as percutaneous transluminal angioplasty catheters, chronic total occlusion catheters, guidewires, fabrics, meshes, introducers, and accessories; valvuloplasty balloons; peripheral vascular stents, self-expanding and balloon-expandable covered stents, and vascular grafts; vena cava filters; biopsy devices; and a range of minimally invasive devices for the treatment of peripheral vascular and end-stage renal diseases. It also provides urology products, including Foley catheters to reduce the rate of urinary tract infections; fecal incontinence products; brachytherapy devices and radioactive seeds for the treatment of prostate cancer; intermittent urinary drainage catheters, and urine monitoring and collection systems etc.

Company Info

BARD C R INC

730 CENTRAL AVE

MURRAY HILL NJ 07974

CEO: Timothy M. Ring

Phone: 908-277-8000

BARD C R INC / BCR FAQ

What is the stock price of BARD C R INC today?

The current stock price of BCR is 331.24 null. The price decreased by -0.59% in the last trading session.


What is the ticker symbol for BARD C R INC stock?

The exchange symbol of BARD C R INC is BCR and it is listed on the New York Stock Exchange, Inc. exchange.


On which exchange is BCR stock listed?

BCR stock is listed on the New York Stock Exchange, Inc. exchange.


What is BARD C R INC worth?

BARD C R INC (BCR) has a market capitalization of 24.14B null. This makes BCR a Large Cap stock.


What are the support and resistance levels for BARD C R INC (BCR) stock?

BARD C R INC (BCR) has a support level at 331.23 and a resistance level at 332.05. Check the full technical report for a detailed analysis of BCR support and resistance levels.


Should I buy BARD C R INC (BCR) stock?

There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:


Does BARD C R INC (BCR) stock pay dividends?

BARD C R INC (BCR) has a dividend yield of 0.24%. The yearly dividend amount is currently 1.04. Check the full fundamental report for a detailed analysis of BCR dividend history, reliability and sustainability.


What is the Price/Earnings (PE) ratio of BARD C R INC (BCR)?

The PE ratio for BARD C R INC (BCR) is 43.42. This is based on the reported non-GAAP earnings per share of 7.63 and the current share price of 331.24 null. Check the full fundamental report for a full analysis of the valuation metrics for BCR.


BCR Technical Analysis

ChartMill assigns a technical rating of 7 / 10 to BCR. When comparing the yearly performance of all stocks, BCR is one of the better performing stocks in the market, outperforming 85.44% of all stocks.


Chartmill TA Rating
Chartmill Setup Rating

BCR Fundamental Analysis

ChartMill assigns a fundamental rating of 5 / 10 to BCR. BCR has an excellent profitability rating, but there are some minor concerns on its financial health.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

BCR Financial Highlights

Over the last trailing twelve months BCR reported a non-GAAP Earnings per Share(EPS) of 7.6288. The EPS increased by 12.33% compared to the year before.


Industry RankSector Rank
PM (TTM) 14.73%
ROA 10.25%
ROE 28.3%
Debt/Equity 0.57
Chartmill High Growth Momentum
EPS Q2Q%-2.12%
Sales Q2Q%5.09%
EPS 1Y (TTM)12.33%
Revenue 1Y (TTM)7.12%

BCR Ownership and Analysts


Ownership
Inst Owners79.11%
Ins Owners0.06%
Short Float %N/A
Short RatioN/A
Analysts
AnalystsN/A
Price TargetN/A
EPS Next Y68.26%
Revenue Next YearN/A